With the right strategy, researchers could fuse clinical trial data with real-world data, according to an article published in the Annals of Internal Medicine.
In the article, according to a Medical Xpress report, Duke University School of Medicine’s Michael Pencina, alongside colleagues Frank Rockhold and Ralph D’Agostino, offer three strategies to introduce tools and methods used in randomized controlled trials to real-world environments.
According to Medical Xpress’ report, the authors say fusing randomization with RWD could “make the trial-eligible population more representative of the actual clinical setting and is equally applicable to large trials and small experiments.”
“Clinical research will benefit greatly from an acceptance that data are complementary, which will result in a much larger universe of health questions to be asked and answered,” the authors write.
To read more on Medical Xpress, click here.